Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

While Tapentadol is a serious habit-forming opioid-based drug, Pregabalin has become a headache in Punjab as it is ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

Ahmedabad: Gujarat Anti-Terrorist Squad (ATS) on Tuesday seized 500kg of Tramadol from an industrial unit in Dholka of ...

After waiting years for an official diagnosis, Saff Khalique was told she had endometriosis aged 25 - and turned to medical ...

to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if your primary abortive medication isn’t effective. To manage migraine episodes ...